Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.2 USD | +0.63% | +8.84% | +12.68% |
05-15 | Transcript : Aytu BioPharma, Inc., Q3 2024 Earnings Call, May 15, 2024 | |
05-15 | Earnings Flash (AYTU) AYTU BIOPHARMA Reports Q3 Revenue $18M, vs. Street Est of $17.4M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.68% | 17.82M | |
+38.51% | 727B | |
+33.05% | 599B | |
-6.23% | 354B | |
+18.78% | 328B | |
+1.35% | 277B | |
+16.00% | 243B | |
+8.09% | 205B | |
-5.77% | 203B | |
+6.19% | 164B |
- Stock Market
- Equities
- AYTU Stock
- News Aytu BioPharma, Inc.
- Aytu Biopharma, Inc. Announces Resignation of Members of the Board of Directors